Cochrane Review: Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review

Zusammenfassung

Carbamazepin im Vergleich zu Phenytoin als Monotherapie bei Epilepsie: ein Review individueller Patientendaten - Nevitt, SJ - 2019 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001911.pub4/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001911.pub4/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, incl

Kerninformationen

1.pub4/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention - [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001911.pub4/information/de#history) Collapse all Expand all ## Abstract a...

into long‐term remission shortly after starting drug therapy with a single antiepileptic drug in monotherapy. Worldwide, carbamazepine and phenytoin are commonly‐used broad spectrum antiepileptic drugs, suitable for most epileptic seizure types. Carbamazepine is a current first‐line treatment for ...

ls may show differences in efficacy. ### Objectives To review the time to treatment failure, remission and first seizure with carbamazepine compared with phenytoin when used as monotherapy in people with focal onset seizures (simple or complex focal and secondarily generalised), or generalised ons...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen